tirzepatide and osa Original Article: for the Treatment of Obstructive Sleep Apnea Obesity (SURMOUNT-OSA) buff.ly/4ccuPKO Editorial: Entering a New Era in Sleep-Apnea Treatment buff.ly/3XyX1D2 In the two SURMOUNT-OSA trials,

Gujiansan ameliorates avascular necrosis of the femoral head by regulating autophagy via the HIF-1/BNIP3 pathway

It is presently accepted that genetic susceptibility, environmental factors, including nutritional factors and immune disorders contribute to the development of AITD

L-carnitine plays an active role by promoting the beta-oxidation of fatty acids present in sebum, notably triglycerides and free fatty acids such as palmitic acid

12885_2025_13546_MOESM3_ESM.tif (download TIF Supplementary Material 3: Supplementary Fig

Yes, higher doses temporarily saturate renal clearance capacity, extending plasma half-life from the standard 68 hours to 911 hours at doses above 35mg

Oliver Morris, DO manages the peptide program personally